February 28, 2022: Fatal outcomes in elderly patients after COVID-19 vaccination Many elderly individuals whose death was linked to the vaccine had preexisting cardiovascular diseases. Genetic predispositions could be also involved.

February 20, 2022: Acute liver failure after COVID-19 vaccination A healthy 34-year-old health care worker with no history of COVID-19 dies from hepatic infarction a few days after his first dose of ChAdOx1nCov-19 vaccine.

February 16, 2022: Catecholamine-Mediated Stress Cardiomyopathy after COVID-19 Infection & Vaccination An overly exuberant immune response to the vaccine can cause myocardial injury mediated by similar immune mechanisms as described with SARS-COV-2 and multisystem inflammatory syndrome (MIS-C) cytokine storms.

February 15, 2022: Fatal breakthrough infections in solid organ transplant recipients 4 case reports of fatal breakthrough infections among liver and kidney transplant recipients aged 13-69.

February 13, 2022: Fatal COVID-19 breakthroughs in kidney disease patients Brazilian and Scottish studies show that patients with kidney disease do not benefit from existing COVID-19 vaccines.

February 2, 2022: Fatal COVID-19 breakthrough in an 88-year-old male Yet another report about a healthy person (except benigh prostate) who dies despite 2 doses of a COVID-19 vaccine

February 2, 2022: Deaths of elderly individuals wrongly given an extra dose of the vaccine. They were given too many doses too soon - due to insufficient documentation or vaccine passport bureaucrats.

February 1, 2022: Who benefits the least from COVID-19 vaccines? Vaccines help some people more than others.

February 1, 2022: Vaccinated 71-year-old male dies from breakthrough COVID-19 on the 2nd day of symptom onset 71-year-old double-vaccinated overweight male started to feel unwell on the 7th day and died on the 9th day - while sitting in his easy chair shortly before an ambulance arrived.

January 30, 2022: Severe breakthrough COVID-19 in vaccinated patients with multiple sclerosis. Multiple sclerosis patients have a higher risk of breakthrough infection

January 21, 2022: Another case report on fatal breakthrough with brain involvement. Neurological manifestations are common in COVID-19. A sudden-onset reversible cerebral vasoconstriction syndrome (RCVS), possibly caused by a transient dysregulation of cerebral vascular tone, is described in this fatal COVID-19 vaccine breakthrough case.

January 18, 2022: Fatal Anorexia caused by COVID-19 vaccination. A 90-year old woman in stable health receives the first dose of the COVID-19 vaccine, experiences inreased heart rate, develops anorexia and dies 28 weeks later.

January 16, 2022: A fatal case of COVID-19 breakthrough infection in a 61-year old man A 61-year-old man with a history of arterial hypertension (PA 145/95 mmHg) and obesity with a body mass index (BMI) of 37.11 was vaccinated with a double dose of mRNA vaccine, but 4 months after the 2nd dose was diagnosed with COVID-19 and died 15 days after diagnosis despite treatment.

January 13, 2022: Young COVID-19 vaccine breakthrough fatalities Vaccine effectiveness may fail for individuals with particular genetics and we need more studies and more medical case reports to develop personalized preventative and curative approaches.

January 12, 2022: Post-infectious body odor A paper posted today on MedRxiv tells that dogs can easily detect long COVID - and not only acute COVID-19 - in at least half of the cases. Vaccine effectiveness may fail for individuals with particular genetics and we need more studies and more medical case reports to develop personalized preventive and curative approaches.

January 8, 2022: Risk Factors for Severe COVID-19 Outcomes Among Vaccinated Individuals New Morbidity and Mortality Weekly Report (MMWR) emphasizes the usual risk factors for fatal breakthroughs: age 65 or older or at least one of these conditions: diabetes mellitus, immunosuppression, chronic kidney disease, chronic liver disease, chronic neurologic disease, chronic cardiac disease, or chronic pulmonary disease.